Author/Authors :
Wang, Xiaoying Department of Immunology - Medical School of Ningbo University - Ningbo - China , Keye Xu Department of Immunology - Medical School of Ningbo University - Ningbo - China , Sisi Chen Department of Immunology - Medical School of Ningbo University - Ningbo - China , Yan Li Department of Immunology - Medical School of Ningbo University - Ningbo - China , Mingcai Li Department of Immunology - Medical School of Ningbo University - Ningbo - China
Abstract :
Interleukin-1 family 7 (IL-1F7) is a novel member of IL-1F cytokines. IL-1F7 is more
commonly known as IL-37. IL-37 can join the α-subunit of the IL-18 receptor, or IL-18
binding protein (IL-18BP), and binding of these proteins can enhance the IL-18
suppression. IL-37 also translocates to the cell nucleus and affects gene transcription.
IL-37 inhibits the phosphorylation of p38 mitogen-activated protein kinases. Almost all
reports showed that IL-37 has remarkable anti-inflammatory activity. IL-37 plays an
important role in a variety of inflammatory and autoimmune diseases. Recently, studies
demonstrated that the expression of IL-37 is abnormal in many diseases such as
inflammatory bowel diseases, inflammatory respiratory diseases, atherosclerosis,
hepatitis, obesity, contact hypersensitivity, Graves’ disease, rheumatoid arthritis,
ankylosing spondylitis, systemic lupus erythematosus, multiple sclerosis, psoriasis, and
Behcet's disease. Here, we will review the biological characteristics of IL-37 and its key
roles in various inflammatory and autoimmune diseases.
Keywords :
Anti-Inflammatory , Inflammation-Related Diseases , Interleukin-37 , Autoimmune Diseases